• The initiative intends to support immediate family members of deceased employees by offering regular employment and financial assistance, in addition to existing employee benefits
• The policy also provides financial support to employees who have lost their kin to Covid-19

At a time when several people are losing lives and livelihood to Covid-19, Venus Remedies Pvt Ltd, a leading research-oriented pharmaceutical company based in Panchkula, has stepped up efforts to offer unflinching support to its employees in these tough times.

Venus Remedies has rolled out a Covid protection policy for its employees and their immediate family members, under which it will pay an amount equivalent to one month of gross salary for the next 12 months to the nominated dependants of permanent employees in case of their untimely demise due to Covid-19.

Over and above this, the company will also offer regular employment to their next eligible kin, spouse or children, as per their qualification and experience, based on the organisation’s standard employment rules.
The support extended to the dependant family members of deceased employees is in addition to the existing employee benefits.

In case of death of an immediate family member, which may include parents, spouse or children, due to COVID-19, Venus Remedies will pay an amount equivalent to one month of basic salary for the next 12 months to the affected employee.

The policy comes into force with effect from July 1 and will be valid up to June 30 next year.

Commenting on the initiative, Mr Akshansh Chaudhary, President, HR, Venus Remedies, said, “Our employees are not only our greatest assets but also our topmost priority, and all our policies are oriented towards their well-being. We sincerely pray that this contribution helps rebuild the lives of those employees and their family members who have been affected by Covid-19. As we renew our commitment to our fight against COVID-19, we are confident that we will overcome these trying times and emerge stronger.”

To ensure the safety and well-being of its employees, Venus Remedies has not only been screening and testing them for Covid-19 on a regular basis, it has also taken the lead in vaccinating them and their immediate family members.

About Venus Remedies
Panchkula-based Venus Remedies Ltd (NSE: VENUSREM, BSE: 526953) is among the 10 leading fixed-dosage injectable manufacturers in the world. Having presence in 75 countries with a portfolio of as many products spread over Europe, Australia, Africa, Asia-Pacific, Commonwealth States, Middle East, Latin America and Caribbean region, the company has nine globally benchmarked facilities in Panchkula, Baddi and Werne (Germany), apart from 11 overseas marketing offices. Its manufacturing units are certified for ISO 9001, ISO 14001, ISO 18001 and OHSAS. The company has also been approved by European-GMP, WHO-GMP and Latin American GMP (INVIMA), among others. Ranked 107th in Asia and among the world’s 500 largest pharmaceutical manufacturing companies, Venus Remedies has won more than 100 patents, 70 trademarks and 12 copyrights for its innovative research products worldwide.

For further information, please contact:
Amardeep Tiwana | Adfactors PR | Phone: 9814046480 | email: amardeep@adfactorspr.com